Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-08 · accession 0000950170-25-037572 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-11 | 2025-03-08+ | TMCI | Scanlan Sean F. | Chief Innovation Off | F - Tax | $0.00 | -1,797 | 365.5K | -0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-10 | F | D | 1,396 | $0.00 | 364,081 | D | — | — | (F2) Includes 325,098 restricted stock units. |
| 2 | Common | Common Stock | 2025-03-08 | F | D | 401 | $0.00 | 365,477 | D | — | — | (F1) Includes 330,829 restricted stock units. |